Prognostic value of pre‐therapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation
In conclusion, pre‐treatment platelet elevation is a promising predictor of prognosis, and further work should be done to elucidate the utility of anti‐platelets in modifying risk in OPC patients. This article is protected by copyright. All rights reserved.
Source: International Journal of Cancer - Category: Cancer & Oncology Authors: Sara Shoultz‐Henley, Adam S. Garden, Abdallah S. R. Mohamed, Tommy Sheu, Michael H. Kroll, David I. Rosenthal, G. Brandon Gunn, Amos J. Hayes, Chloe French, Hillary Eichelberger, Jayashree Kalpathy‐Cramer, Blaine D. Smith, Jack Phan, Zeina Ayoub, Step Tags: Cancer Therapy Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Intensity-Modulated Radiation Therapy | Oropharyngeal Cancer | Phlebotomy | Radiation Therapy | Study